Activation of imidazoline‐I3 receptors ameliorates pancreatic damage
- 26 June 2015
- journal article
- research article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 42 (9) , 964-971
Abstract
Agmatine, an endogenous ligand of imidazoline receptors, is reported to exhibit anti‐hyperglycaemic and many other effects. It has been established that the imidazoline I3 receptor is involved in insulin secretion. The current study characterizes the role of the imidazoline I3 receptor in the protection of pancreatic islets. The activity effect of agmatine against on streptozotocin (STZ)‐induced (5 mmol/L) rat β cell apoptosis was examined by using ApoTox‐Glo triplex assay, live/dead cell double staining assay, flow cytometric analysis, and western blot. Imidazoline I3 receptors antagonist KU14R and the phospholipase C inhibitor named U73122 were treated in β cells to investigate the potential signalling pathways. The serum glucose and recovery of insulin secretion were measured in STZ‐treated rats after continuously injected agmatine. The apoptosis in rat β cells was reduced by agmatine in a dose‐dependent manner, cell viability was improved after treatment with agmatine and these effects were suppressed after the blockade of KU14R and U73122. Western blot analysis confirmed that agmatine could decrease caspase‐3 expression and increase the p‐BAD levels. In STZ‐treated rats, injection of agmatine for 4 weeks may significantly lower the serum glucose and recovery of insulin secretion. This improvement of pancreatic islets induced by agmatine was deleted by KU14R in vivo. Agmatine can activate the imidazoline I3 receptor linked with the phospholipase C pathway to induce cell protection against apoptosis induced by a low dose of STZ. This finding provides new insight into the prevention of early stage pancreatic islet damage.Keywords
This publication has 36 references indexed in Scilit:
- Agmatine: clinical applications after 100 years in translationDrug Discovery Today, 2013
- GLP-1 Mediates Antiapoptotic Effect by Phosphorylating Bad through a β-Arrestin 1-mediated ERK1/2 Activation in Pancreatic β-CellsJournal of Biological Chemistry, 2010
- Apoptosis of metastatic prostate cancer cells by a combination of cyclin-dependent kinase and AKT inhibitorsThe International Journal of Biochemistry & Cell Biology, 2009
- Streptozotocin-induced diabetes increases the interaction of Bad/Bcl-XL and decreases the binding of pBad/14–3–3 in rat testisLife Sciences, 2007
- Caspase-dependent and -independent pathways for cadmium-induced apoptosis in cultured kidney proximal tubule cellsAmerican Journal of Physiology-Renal Physiology, 2006
- High glucose potentiates cytokine- and streptozotocin-induced apoptosis of rat islet cells: effect on apoptosis-related genesJournal of Endocrinology, 2004
- Comparative Effects of Efaroxan and b‐Carbolines on the Secretory Activity of Rodent and Human b CellsAnnals of the New York Academy of Sciences, 2003
- Activation of Raf-1 Signaling by Protein Kinase C through a Mechanism Involving Raf Kinase Inhibitory ProteinJournal of Biological Chemistry, 2003
- Mechanisms of Coxsackievirus-Induced Damage to Human Pancreatic -CellsThe Journal of Clinical Endocrinology & Metabolism, 2000
- Clinical Pharmacology of Drugs Acting on Imidazoline and Adrenergic ReceptorsAnnals of the New York Academy of Sciences, 1995